Top compounds associated with response to PRR13


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA PD318088 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA Curcumin CTRPv2 pan-cancer AAC -0.1 0.004
mRNA PI-103 CTRPv2 pan-cancer AAC -0.1 0.004
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.1 0.004
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.005
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.005
mRNA IC-87114 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA Parthenolide CTRPv2 pan-cancer AAC -0.11 0.005
Download CSV